Reduced tear output can arise from altered neural regulation, impaired epithelial secretion, or loss of secretory tissue, with different implications for recovery. This focused narrative review integrates physiological, single-cell, spatial, organoid, and mechanistic studies identified through a structured PubMed search and targeted reference checking. We examine how remodeling of the lacrimal secretory niche affects acinar secretory competence, the capacity of viable acinar cells to convert stimulation into coordinated fluid, electrolyte, and protein secretion. Omics studies identify disease-associated expression patterns and candidate interactions, while selected perturbation studies link neural, inflammatory, and metabolic mechanisms to secretory dysfunction. We use residual functional reserve as a working concept for secretion that surviving tissue and its supporting niche can recruit through stimulation or relief of suppression. Potentially reversible functional suppression, persistent niche dysfunction, and structural failure describe overlapping constraints on secretion, not validated disease stages. These descriptions are distinct from the cellular, glandular, and lacrimal functional-unit levels at which outcomes are measured. The framework organizes questions about mechanism and recovery but does not establish a clinical treatment algorithm. Progress requires functional testing of candidate mechanisms and assessment of recovery at the level relevant to each claim.
Dry eye disease (DED) exposes the ocular surface to persistent hyperosmolar, oxidative, metabolic, and inflammatory stress that may increase susceptibility to ferroptosis. Whether autophagy promotes or limits ferroptotic injury in DED remains unresolved. This review critically evaluates evidence from corneal and conjunctival epithelia, lacrimal glands, and meibomian glands, using non-ocular models only to interpret mechanisms not yet resolved in ocular tissues. We propose a threshold-balance framework in which autophagy has context-dependent effects. Ferritinophagy, lipophagy, and impaired autophagic flux can expand the labile iron pool, mobilize peroxidizable lipids, and promote lipid peroxidation. Conversely, intact autophagic–lysosomal flux and mitophagy can remove damaged cargo, limit mitochondrial oxidative stress, and preserve membrane antioxidant defenses. The balance between these processes may determine whether stressed ocular-surface cells adapt or progress toward ferroptotic injury, with consequences for epithelial barrier integrity, tear-film homeostasis, glandular secretion, and inflammation. Studies combining autophagy-related pathway perturbation with ferroptosis-related outcomes are concentrated in ocular-surface epithelial models, whereas this relationship has been less directly examined in lacrimal and meibomian tissues. Establishing causality will require flux-aware measurements, targeted pathway perturbation, tissue-resolved models, and functional validation in human samples. Such studies should clarify when and where autophagy–ferroptosis crosstalk is therapeutically actionable in DED.